Three years after the devastating attack on the Nova music festival in October 2023, a critical question remains for medical professionals: what does true recovery look like for survivors? This question centered on the second annual SafeHeart conference, held on November 11 at the Peres Center for Peace and Innovation in Jaffa. The event brought together researchers, clinicians, and family members to explore the evolving landscape of trauma care, including the emerging field of psychedelic-assisted therapy and the vital role of community support.

Prof. Rachel Yehuda, a trauma researcher at the Icahn School of Medicine at Mount Sinai, emphasized the need for caution when treating survivors with psychedelics. Yehuda, who directs the Parsons Research Center for Psychedelic Healing, noted that many survivors were under the influence of psychoactive substances when the attack began. She argued that another altered state of consciousness should not be the default first step in treatment. Instead, she highlighted the importance of distinguishing between an experience that offers escape and one that helps a person process trauma.

Yehuda stressed that the approval and implementation of psychedelic medicines in Israel must prioritize the surrounding psychological care, not just the drugs themselves. She stated that supportive therapy is essential and that therapists require specific training before treatment patterns become widespread. This approach ensures that patients are properly prepared and supported after their sessions, addressing the full scope of their mental health needs.

New data presented at the conference offers insight into the biological and behavioral factors influencing recovery. Researchers from the University of Haifa, including Prof. Roee Admon and Roy Salomon, shared findings from a large observational study involving over 1,200 survivors. One preliminary analysis suggested that higher levels of a specific inflammatory protein in saliva shortly after the attack were associated with more severe post-traumatic stress symptoms later on. While these results are not yet published, they point to potential biological markers for identifying those at higher risk.

The study also examined substance use in the months following the attack. Among 453 survivors surveyed between eight and 12 months after the event, approximately 70% reported using more than one type of psychoactive substance, including alcohol. Researchers used language models to analyze survivors' accounts of their substance use, aiming to understand the reasons behind these patterns. Although these associations do not prove causation, they help clinicians understand the complex relationship between coping mechanisms and mental health outcomes.

Prof. Yuval Neria of Columbia University presented data highlighting the persistence of symptoms. In a study of 392 survivors, about 65% remained above the screening threshold for probable PTSD at eight to 12 months. His research showed that roughly 55% of the group experienced either persistently high or worsening symptoms, challenging the notion that time naturally heals all wounds. Neria also identified childhood adversity and poor sleep as factors associated with lower resilience, urging clinicians to address these issues early in treatment.

The concept of moral injury was also a key topic. Neria described this as lasting distress stemming from experiences that violate deeply held moral beliefs. For Nova survivors, this often manifests as guilt over surviving while friends were killed or taken hostage, or a sense of betrayal regarding the timing of rescue. Clinicians are encouraged to explore these feelings of guilt and shame alongside fear to help survivors rebuild their trust and sense of connection.

The human cost of the trauma was highlighted by Ronen Shalev, whose son survived the festival but died by suicide in October 2025. Shalev spoke about the difficulty of recognizing internal suffering and urged professionals to actively seek out struggling individuals. His account underscored the importance of supporting relatives, who often find themselves navigating a complex and changing landscape of care.

SafeHeart CEO Efrat Atun emphasized that effective recovery requires long-term commitment. The organization provides various services, including individual therapy, group support, and retreats. As researchers continue to investigate why symptoms persist and how biological factors contribute to vulnerability, the consensus is clear: continuity of care is essential. The goal is not just to help survivors get through the week, but to reach a point where trauma is part of their life without governing it.

The conference reinforced that while the immediate crisis has passed, the clinical and emotional challenges remain significant. By combining rigorous research with compassionate, long-term support, the medical community aims to better understand the unique needs of Nova survivors. The focus remains on creating a holistic approach that addresses biological markers, psychological processing, and the social context in which survivors must rebuild their lives.